English | Español

Merck & Company, Inc.
Bree Gonzales | Feb 2, 2022

Molnupiravir is now the last choice for COVID-19: 'The Merck product is only 30% effective'
Press release submission | Sep 23, 2019

MERCK: New Data at ESMO 2019 for Merck KGaA, Darmstadt, Germany, Highlight Focused Clinical Development and Commitment to Patient Care

Trending
+ Pharmaceuticals
Patient Daily | Oct 22, 2024

Bristol Myers Squibb funds $2.25M cervical cancer project in Malawi
+ Pharmaceuticals
Patient Daily | Oct 21, 2024

Baylor professors Bottazzi and Davis elected to National Academy of Medicine
+ Pharmaceuticals
Patient Daily | Oct 22, 2024

American Lung Association welcomes three leaders to Georgia board
+ Pharmaceuticals
Patient Daily | Oct 24, 2024

Dr. Huda Zoghbi honored by American Academy for her contributions to science